Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of obstructive jaundice on clinical pharmacodynamics of propofol
ChiCTR-OPC-16008528Phase 4Recruiting
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of propofol in cholangiocarcinoma (CCA), pancreatic cancer (PC) and obstructive jaundice, sponsored by Eastern Hepatobiliary Surgery Hospital. Primary endpoint: Requirement of propofol. Started May 2016; status: recruiting.
02
Drugs
propofol
03
Conditions
cholangiocarcinoma (CCA)pancreatic cancer (PC)obstructive jaundice
Beyond the preview
Go deeper on ChiCTR-OPC-16008528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16008528.